LARIAM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lariam, and what generic alternatives are available?
Lariam is a drug marketed by Roche and is included in one NDA.
The generic ingredient in LARIAM is mefloquine hydrochloride. There are six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the mefloquine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lariam
A generic version of LARIAM was approved as mefloquine hydrochloride by BARR on December 29th, 2003.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LARIAM?
- What are the global sales for LARIAM?
- What is Average Wholesale Price for LARIAM?
Summary for LARIAM
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 42 |
Clinical Trials: | 3 |
Patent Applications: | 4,122 |
DailyMed Link: | LARIAM at DailyMed |
Recent Clinical Trials for LARIAM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
M.D. Anderson Cancer Center | Phase 1 |
National Cancer Institute (NCI) | Phase 1 |
Liverpool School of Tropical Medicine | Phase 2/Phase 3 |
US Patents and Regulatory Information for LARIAM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Roche | LARIAM | mefloquine hydrochloride | TABLET;ORAL | 019591-001 | May 2, 1989 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LARIAM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Roche | LARIAM | mefloquine hydrochloride | TABLET;ORAL | 019591-001 | May 2, 1989 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LARIAM
See the table below for patents covering LARIAM around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | H0255432 | ⤷ Sign Up | |
Austria | 55387 | ⤷ Sign Up | |
European Patent Office | 0137375 | MEFLOQUINIC HYDROCHLORIDE | ⤷ Sign Up |
Germany | 3482926 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |